Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varenicline for smoking cessation in smokers with type 2 diabetes
2009-017599-26Phase 4Active
- Sponsor
- Centro per la Prevenzione e Cura del Tabagismo
- Start
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in nicotine dependence comparing Varenicline with Placebo (2 arms). Primary endpoints: Continuous quit rate at week 24 and Continuous quit rate during weeks 8 to 12. Started Jan 2010; status: active.
02
Drugs
varenicline
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on 2009-017599-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017599-26.